Development of an Online Cardiovascular Pre-participation Screening Tool: The Community and Athletic Cardiovascular Health Network Screening Portal [0.03%]
心血管参与前筛查在线工具的开发：社区及运动心脏健康网络筛查平台
Nicholas Grubic,Amer M Johri;CATCH Network
Nicholas Grubic
Neurodevelopment in Children With Congenital Heart Disease: An Opportunity for the Cardiovascular Trainee [0.03%]
先天性心脏病儿童神经发育：心血管培训师的机会
Devin Chetan,Thiviya Selvanathan,Jawad Alzamil et al.
Devin Chetan et al.
Utility of Substrate Mapping Using Extrasystole to Localise Comprehensive Ventricular Tachycardia Circuits: Results From Intra-operative Mapping Studies [0.03%]
使用逸搏定位全面性室速环路的贴壁标测的临床应用价值：术中研究结果
Maroosh Mumtaz,Eugene Downar,Satoshi Kawada et al.
Maroosh Mumtaz et al.
Background: Substrate mapping-based identification of all ventricular tachycardia (VT) circuits (diastolic activation), including partial and complete diastolic circuits in clinical and nonclinical VT, could be beneficial...
Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE Study [0.03%]
在全民医疗保健体系中患有动脉粥样硬化性心血管疾病的不同种族和族裔的患者：来自CARTaGENE研究的新见解
Marc-André d&#x;Entremont,Dennis Ko,Andrew T Yan et al.
Marc-André d&#x;Entremont et al.
Background: It remains unclear whether racial and ethnic disparities for atherosclerotic cardiovascular disease (ASCVD) persist within universal health care systems. We aimed to explore long-term ASCVD outcomes within a s...
The Impact of COVID-19 on the Social Determinants of Cardiovascular Health [0.03%]
COVID-19对心血管健康社会决定因素的影响
Mark A Faghy,Ruth E M Ashton,Lewis Gough et al.
Mark A Faghy et al.
Cardiovascular disease is the leading noncommunicable disease and cause of premature mortality globally. Despite well established evidence of a cause-effect relationship between modifiable lifestyle behaviours and the onset of risk of chron...
Effect of COVID-19 Infection in Patients Who Present With Acute Myocardial Infarction and Cardiogenic Shock [0.03%]
COVID-19感染对急性心肌梗死合并心源性休克患者的影响
Ameesh Isath,Aaqib Malik,Dhrubajyoti Bandyopadhyay et al.
Ameesh Isath et al.
Screening for TMVR: A Glimpse Into the Future Technological Needs and Requirements [0.03%]
TMVR筛选：未来技术需求和要求的展望
Andrea Scotti,Augustin Coisne,Juan F Granada
Andrea Scotti
Andrew J Gorton,Suresh Keshavamurthy,Arkalgud Sampath Kumar
Andrew J Gorton
Mohsyn Imran Malik,Rami M Abazid,Sabe De et al.
Mohsyn Imran Malik et al.
Is It Time to Relitigate SGLT2 Inhibitor Dose for Heart Failure? [0.03%]
评估心脏衰竭患者钠-葡萄糖协同转运蛋白-2抑制剂的剂量是否足够？
Jonathan G Howlett
Jonathan G Howlett